Report
Emmanuel Matot

Arkema : Q2 2020 publication reflecting the big impact of the health crisis

>Strong fall in earnings in Q2 but not as big as expected – Excellent FCF generation - Arkema has just reported its Q2 2020 results. EBITDA, the key indicator, showed a sharp fall of 30% to € 286m (after -19% in Q1) but came in ahead of expectations (consensus = € 261m). Amid a serious health crisis, volumes fell 12% (transport, industry and construction sectors particularly hard hit).All divisions posted declines (volumes, sales, EBITDA and EBITDA margin), the b...
Underlying
ARKEMA

Arkema is engaged in the global chemical industry which is a processing industry based on the transformation in one or several stages of raw materials (oil derivatives, gas, minerals, natural products) into more or less complex chemical products, or into plastics obtained by polymerization. In addition, Co. manufactures a wide range of products for other major industries: construction, packaging, chemicals, automotive, electronics, food manufacturing, pharmaceuticals, etc. Co. operates in this industrial context with a business portfolio focused on three segments: High Performance Materials, Industrial Specialties, and Coating Solutions.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Emmanuel Matot

Other Reports on these Companies
Other Reports from Oddo BHF

ResearchPool Subscriptions

Get the most out of your insights

Get in touch